The Next 'Ozempic Moment' Could Be in Heart Disease

Just as Ozempic rewrote the obesity playbook, this breakthrough data could transform how we treat inflammatory heart disease. Fully funded. Multiple catalysts. $280B market opportunity.

Brazil's currency drops to weakest level yet as Lula's fiscal measures debated

MAURICIO SAVARESE
December 18, 2024

SAO PAULO (AP) -- Brazil's real on Wednesday fell to its weakest level against the dollar since the currency was introduced in 1994, undercut by investors' frustration with President Luiz Inácio Lula da Silva's efforts to rein in government spending.

A bill backed by Lula that aims to slash 70-billion-real ($11 billion) in government spending is being debated in Brazil's lower house of Congress. But some market players have said it is insufficient to shore up Brazil's finances.

The real shed 2.8% of its value against the U.S. dollar Wednesday, depreciating to 6.26 per dollar. It's the weakest the currency has been in nominal terms since its adoption in an economy with a history of boom-and-bust cycles and bouts of high inflation.

This year, it has lost nearly 23% of its value against the U.S. currency.

Brazil's lower house late Tuesday passed some less-divisive elements of the bill, but key parts -- such as restrictions to increases in the minimum wage -- have yet to be taken up for a vote. The Senate also needs to vote on what the lower house approves, and Congress adjourns Friday.

Brazil's central bank has repeatedly intervened in local currency markets to stem the real's slide but so far has largely failed to stop the bleeding. Economists say the currency's weakness, which will increase costs of Brazilian imports, could trigger inflation as soon as January.

"The government sent a package that is seen as insufficient, and it will be watered down in Congress. It also comes with a measure to increase spending through income tax," analyst Mario Sérgio Lima, from Medley Advisors, told The Associated Press. "The real at 6 per dollar looks acceptable, but nearing 6.30 looks like an exaggeration."

Lula, who is recovering from surgery to stop a brain bleed, told TV Globo on Sunday that his administration is fiscally responsible and downplayed concerns in the financial markets.

"It is not the market that needs to be worried about government spending. It is our administration. If I don't rein in spending, if I spend more than I have, it is the poor people who will pay for it," the Brazilian president said.

Brazil's Economy Minister Fernando Haddad said the real's steep depreciation does not reflect the realities of the country's economy, noting that inflation and unemployment figures are improving.

"Some are talking about speculation, including respectable journalists," Haddad told journalists in Brazil's capital, Brasilia, without providing more details. "Our currency floats and at this moment, when some things are pending (in Congress), there's an atmosphere of uncertainty that makes the currency float. But I believe it will find its ground."

Continue Reading...

Popular

Trump Signs Law to Launch Dollar 2.0 - Ad

Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.

Velo3D Stock Soars After Q3 Earnings: Highlights From The Report

Shares of Velo3D, Inc. (NASDAQ:VELO) are rising Tuesday after the metal 3D printing company reported third-quarter earnings results.

Indigenous groups get the spotlight at UN climate talks, but some say visibility isn't power

BELEM, Brazil (AP) — Indigenous people are used to adapting, so when the power failed at their kickoff event at this year's , they rolled with it. Participants from around the world sweated through song, dance and prayers, improvising without microphones and cooling themselves with fans made of paper or leaves.

Is Big Pharma's Next Target Already in Play? - Ad

A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.

First Drug to Show Breakthrough Myocarditis Data. Analysts See Potential 7-10x Upside. - Ad

This biotech just delivered a medical first in myocarditis and has a Phase 3 trial fully funded into 2027. Wall Street targets imply massive revaluation ahead.

Swiss prosecutors target Credit Suisse, now part of UBS, over Mozambique money laundering case

GENEVA (AP) — Swiss authorities on Monday said they have indicted a former official at Credit Suisse — now part of Swiss banking titan UBS — for alleged money laundering in a case involving state companies in Mozambique, and charged the bank with not doing enough to stop it.

The Smart Money Copper Trade - Ad

Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.

Marjorie Taylor Greene Goes Bargain Shopping, Discloses Buying These Two Stocks At 52-Week Lows

Congresswoman Marjorie Taylor Greene disclosed some new stocks recently. Unlike past trades in 2024 and 2025, the latest disclosure is rather unique.

Shutdown to leave mark on US economy from lost paychecks, canceled flights

WASHINGTON (AP) — The longest federal government shutdown in U.S. history appears to be nearing an end, but not without leaving a mark on an already-struggling economy.

A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad

Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.

China's car sales slow in October as some trade-in subsidies, tax breaks are phased out

BANGKOK (AP) — China's passenger car sales slowed in October, even for electric vehicle makers BYD and Tesla, as automakers cut prices to compete in an overcrowded market, an industry association said Tuesday.

How Tyson's Chicken Business Will Offset Beef Weakness

Tyson shares rise as pricing catch-up expected to ease cost pressures; chicken strength offsets beef headwinds amid stable feed costs.

Copper, Silver, Gold, Tungsten - This Nevada Play Offers Multiple Shots on Goal - Ad

Most early-stage resource opportunities rely on one metal. This one doesn't. The Walker Lane belt hosts copper, silver, gold, and tungsten - and recent results across the district confirm all four. This startup has stepped in with multi-metal exposure, giving investors several potential ways to capture upside.

A lost generation of news consumers? Survey shows how teenagers dislike the news media

NEW YORK (AP) — Cat Murphy, a college student, has wanted to be a journalist since she was 11. Many of her friends don't understand why.

Covet an Italian masterpiece, but shy of the millions? How about a digital copy at supercar prices

MILAN (AP) — The last person to get their hands on a painting attributed to Leonardo da Vinci shelled out Now, Italian cultural officials are making it possible to purchase a limited edition, certified digital copy of the Renaissance genius’ “Lady with Disheveled Hair’’ for roughly the price of a Lamborghini.

Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad

AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.

Movie Review: Time has outrun this 'Running Man'

It’s always interesting when time overtakes the dystopias of the past. In 1982 novel “The Running Man,” the United States has fallen into a totalitarian state, divided between haves and have-nots, where all movements can be surveilled and realistic video propaganda is easily generated. King’s book was set in the year 2025.

These are the 37 donors helping pay for Trump's $300 million White House ballroom

WASHINGTON (AP) — President Donald Trump says his $300 million White House ballroom will be paid for “100% by me and some friends of mine.”

Urgent Copper Stock With Strong Catalysts - Ad

Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.

Dogecoin Fakes A Rally Then Dumps 3%—But Why?

Dogecoin (CRYPTO: DOGE) fell close to 3% on Tuesday, as large holders shifted roughly $32 million worth of DOGE to exchanges, putting sellers back in control.

Analyst Sees Strong Medtronic Momentum Through 2026 With Buy Rating Intact

BofA expects Medtronic to post over 5% second-quarter revenue growth and maintain strong momentum through 2026, driven by robust procedure trends.

Weiss Gold Veteran Makes Shocking New Call - Ad

Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.

Why 12-Year-Old Mark Zuckerberg Built A Little Messaging Network For The Family Member Who Reportedly Wrote Him $100,000 Check To Start Facebook

Preteen Mark Zuckerberg's early coding projects, including the family messaging system ZuckNet, combined with strong family support and a reported $100,000 check from his father, foreshadowed his creation of Facebook and Meta's later rise to a $1.54 trillion company.

Weekend Round-Up: Airbus Chaos, BYD's Massive Recall, Tesla's Free FSD Rides, Rivian's Tax Credit Silver Lining And More

From emergency aircraft recalls to massive vehicle recalls in China, to free self-driving rides in Europe, the past week was buzzing in the auto and tech sector.

The Next 'Ozempic Moment' Could Be in Heart Disease - Ad

Just as Ozempic rewrote the obesity playbook, this breakthrough data could transform how we treat inflammatory heart disease. Fully funded. Multiple catalysts. $280B market opportunity.

Trump Bars South Africa From 2026 G20 Summit In Florida, Freezes Aid Over 'White Genocide'

President Donald Trump directed that South Africa will not be invited to the 2026 G20 Summit in Miami, Florida. He also declared that all U.S. payments and subsidies to the country would be immediately suspended.

OpenAI's Partners Rake Up $96 Billion Debt as AI Industry's Borrowing Trend Escalates

Companies supplying data centers, chips, and processing power to OpenAI have racked up a staggering $96 billion in debt to fund their operations.

Trump Signs Law to Launch Dollar 2.0 - Ad

Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.

Axon Enterprise: From TASER To AI-Powered Public Safety Platform

Axon Enterprise is executing an interesting transition from hardware vendor to high-margin SaaS and AI platform...

Nvidia, Dell, Coinbase, Gorilla Technology And Archer Aviation: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks closed lower on Monday, with the Dow slipping 1.2% to 46,590.24, the S&P 500 easing 0.92% to 6,672.41, and the Nasdaq dipping 0.84% to 22,708.07. These are the top stocks that gained the attention of retail traders and investors through the day:

Is Big Pharma's Next Target Already in Play? - Ad

A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.

First Drug to Show Breakthrough Myocarditis Data. Analysts See Potential 7-10x Upside. - Ad

This biotech just delivered a medical first in myocarditis and has a Phase 3 trial fully funded into 2027. Wall Street targets imply massive revaluation ahead.

Why Is Occidental Petroleum Stock Gaining Tuesday?

Analysts highlight OXY's robust earnings, production guidance, and expanded resource base as key growth drivers.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright technicaltrading.org
Privacy Policy | Terms of Service